Literature DB >> 32025782

Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT.

Chiara Del Noce1,2, Aldo Vagge3,4, Massimo Nicolò1,2, Carlo Enrico Traverso1,2.   

Abstract

PURPOSE: The aim of this study was to evaluate changes in choroidal thickness and in choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) and their relationship with clinical features and disease activity using spectral domain optical coherence tomography (SD-OCT) and Angio-OCT technology.
METHODS: Eighteen patients and control subjects underwent a complete eye examination, OCT, and Angio-OCT. We also obtained angiographic scans at 3 different consecutive levels (L1, L2, and L3) below the choriocapillary.
RESULTS: The subfoveal choroid was significantly thicker in TAO patients than the control eyes (285.6275 ± 32.5 μm compared with 135.89 ± 19.8 μm, respectively, p = 0.0089). The correlation analysis in the TAO group showed a significant correlation between the choroidal thickness and EUGOGO clinical score (r = 0.84, p = 8.44032E-07). Vascular flow of choriocapillary was markedly reduced in subjects with TAO compared with healthy subjects (49.78 ± 4.5 vs. 53.36 ± 1.07; p = 2.5105E-07) and vascular flow of the deeper layer L3 resulted higher in subjects with TAO than in healthy subjects (46.9 ± 20.23 and 41.475 ± 3.06; p = 0.01168).
CONCLUSIONS: Subfoveal choroidal thickness and choroidal blood flow were significantly different in patients with TAO compared with healthy subjects.

Entities:  

Keywords:  Angio-OCT; Choroid; OCT; Orbitopathy; Thyroid

Year:  2020        PMID: 32025782     DOI: 10.1007/s00417-020-04616-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

Review 1.  Color Doppler imaging of orbital vessels: personal experience and literature review.

Authors:  François Tranquart; Olivier Bergès; Patricia Koskas; Sophie Arsene; Christian Rossazza; Pierre-Jean Pisella; Léandre Pourcelot
Journal:  J Clin Ultrasound       Date:  2003-06       Impact factor: 0.910

2.  Graves' ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score.

Authors:  Bahar Yanik; Işik Conkbayir; Golge Acaroglu; Baki Hekimoglu
Journal:  J Clin Ultrasound       Date:  2005-10       Impact factor: 0.910

3.  Choroidal Thickness in Patients with Graves' Ophthalmopathy.

Authors:  Sinan Çalışkan; Mutlu Acar; Canan Gürdal
Journal:  Curr Eye Res       Date:  2016-07-15       Impact factor: 2.424

4.  Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy.

Authors:  B Özkan; Ç A Koçer; Ö Altintaş; L Karabaş; A Z Acar; N Yüksel
Journal:  Eye (Lond)       Date:  2016-06-17       Impact factor: 3.775

5.  Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.

Authors:  Massimo Nicolò; Raffaella Rosa; Donatella Musetti; Maria Musolino; Michela Saccheggiani; Carlo Enrico Traverso
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

6.  Color Doppler imaging of orbital venous flow in dysthyroid optic neuropathy.

Authors:  Y Nakase; T Osanai; K Yoshikawa; Y Inoue
Journal:  Jpn J Ophthalmol       Date:  1994       Impact factor: 2.447

Review 7.  The multifunctional choroid.

Authors:  Debora L Nickla; Josh Wallman
Journal:  Prog Retin Eye Res       Date:  2009-12-29       Impact factor: 21.198

8.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

9.  Influence of scleral buckling surgery with encircling band on subfoveal choroidal thickness in long-term observations.

Authors:  Dominik Odrobina; Iwona Laudańska-Olszewska; Piotr Gozdek; Mariusz Maroszyński; Michael Amon
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

10.  Analysis in Choroidal Thickness in Patients with Graves' Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography.

Authors:  Nan Yu; Yadi Zhang; Lei Kang; Ying Gao; Junqing Zhang; Yuan Wu
Journal:  J Ophthalmol       Date:  2018-12-23       Impact factor: 1.909

View more
  5 in total

1.  Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT.

Authors:  Chiara Del Noce; Matilde Roda; Lorenzo Ferro Desideri; Carlo E Traverso; Aldo Vagge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-09-01       Impact factor: 3.117

2.  Assessment of Choroidal Vascularity and Choriocapillaris Blood Perfusion After Accommodation in Myopia, Emmetropia, and Hyperopia Groups Among Children.

Authors:  Xuejiao Chang; Mu Li; Liang Lv; Xiaoqin Yan; Ying Liu; Mengxia Zhu; Junming Wang; Ping Wang; Yan Xiang
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

3.  Evaluation of Microcirculation in Optic Nerve Head Using Laser Speckle Flowgraphy in Active Thyroid Eye Disease.

Authors:  Margaret Ming-Chih Ho; Yueh-Ju Tsai; Yen-Chang Chu; Yi-Lin Liao
Journal:  Biomed Res Int       Date:  2022-03-16       Impact factor: 3.411

4.  Evaluation of peripapillary vascular flow in patients with Thyroid-Associated Ophthalmopathy (TAO) by OCT Angiography.

Authors:  Chiara Del Noce; Matilde Roda; Nicola Valsecchi; Sofia Guandalini; Natalie Di Geronimo; Costantino Schiavi; Carlo Enrico Traverso; Aldo Vagge
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-12       Impact factor: 3.535

5.  Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography.

Authors:  Lanchu Yu; Qin Jiao; Yu Cheng; Yanji Zhu; Zhongjing Lin; Xi Shen
Journal:  BMC Ophthalmol       Date:  2020-10-20       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.